Dimerix Limited
Dimerix Limited (DXB) is a biotechnology company focused on the development of innovative therapies for serious diseases. The company operates primarily in the pharmaceutical sector, concentrating on the discovery and development of drugs that target unmet medical needs, particularly in areas such as kidney disease and inflammation. Dimerix's core products include its lead drug candidates, which are being developed to treat conditions such as Focal Segmental Glomerulosclerosis (FSGS) and other chronic inflammatory diseases.